Akt/mammalian target of rapamycin counteract the antitumor activities of cixutumumab an anti-insulin-like growth factor I receptor monoclonal antibody

Documenti analoghi

• Mammalian target of rapamycin, Akt, and phosphatidylinositol 3-kinase signaling
  di: Pal, Sumanta K., et al.
  Pubblicazione: (2010)
• The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody Cixutumumab
  di: Busaidy, Naifa L., et al.
  Pubblicazione: (2015)
• Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin
  di: Huffman, Todd A., et al.
  Pubblicazione: (2002)
• The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling
  di: Yoon, Mee-Sup
  Pubblicazione: (2017)
• Threonine-120 Phosphorylation Regulated by Phosphoinositide-3-Kinase/Akt and Mammalian Target of Rapamycin Pathway Signaling Limits the Antitumor Activity of Mammalian Sterile 20-Like Kinase 1
  di: Collak, Filiz Kisaayak, et al.
  Pubblicazione: (2012)